Faysal G Saab1, Jeffrey N Chiang2, Rachel Brook3, Paul C Adamson4, Jennifer A Fulcher4, Eran Halperin2,5,6,7,8,9, Vladimir Manuel5,10, David Goodman-Meza4. 1. David Geffen School of Medicine, Ronald Reagan UCLA Medical Center, 757 Westwood Blvd., Suite 7501, Los Angeles, CA, 90095, USA. fsaab@mednet.ucla.edu. 2. Department of Computational Medicine, UCLA, California, Los Angeles, USA. 3. David Geffen School of Medicine, Ronald Reagan UCLA Medical Center, 757 Westwood Blvd., Suite 7501, Los Angeles, CA, 90095, USA. 4. Division of Infectious Diseases, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA. 5. UCLA Clinical and Translational Science Institute, Los Angeles, CA, USA. 6. Department of Computer Science, UCLA, Los Angeles, CA, USA. 7. Department of Anesthesiology and Perioperative Medicine, UCLA, Los Angeles, CA, USA. 8. Department of Human Genetics, UCLA, Los Angeles, CA, USA. 9. Institute of Precision Health, UCLA, Los Angeles, CA, USA. 10. Faculty Practice Group, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
Abstract
BACKGROUND: As the SARS-CoV-2 pandemic continues, little guidance is available on clinical indicators for safely discharging patients with severe COVID-19. OBJECTIVE: To describe the clinical courses of adult patients admitted for COVID-19 and identify associations between inpatient clinical features and post-discharge need for acute care. DESIGN: Retrospective chart reviews were performed to record laboratory values, temperature, and oxygen requirements of 99 adult inpatients with COVID-19. Those variables were used to predict emergency department (ED) visit or readmission within 30 days post-discharge. PATIENTS (OR PARTICIPANTS): Age ≥ 18 years, first hospitalization for COVID-19, admitted between March 1 and May 2, 2020, at University of California, Los Angeles (UCLA) Medical Center, managed by an inpatient medicine service. MAIN MEASURES: Ferritin, C-reactive protein, lactate dehydrogenase, D-dimer, procalcitonin, white blood cell count, absolute lymphocyte count, temperature, and oxygen requirement were noted. KEY RESULTS: Of 99 patients, five required ED admission within 30 days, and another five required readmission. Fever within 24 h of discharge, oxygen requirement, and laboratory abnormalities were not associated with need for ED visit or readmission within 30 days of discharge after admission for COVID-19. CONCLUSION: Our data suggest that neither persistent fever, oxygen requirement, nor laboratory marker derangement was associated with need for acute care in the 30-day period after discharge for severe COVID-19. These findings suggest that physicians need not await the normalization of laboratory markers, resolution of fever, or discontinuation of oxygen prior to discharging a stable or improving patient with COVID-19.
BACKGROUND: As the SARS-CoV-2 pandemic continues, little guidance is available on clinical indicators for safely discharging patients with severe COVID-19. OBJECTIVE: To describe the clinical courses of adult patients admitted for COVID-19 and identify associations between inpatient clinical features and post-discharge need for acute care. DESIGN: Retrospective chart reviews were performed to record laboratory values, temperature, and oxygen requirements of 99 adult inpatients with COVID-19. Those variables were used to predict emergency department (ED) visit or readmission within 30 days post-discharge. PATIENTS (OR PARTICIPANTS): Age ≥ 18 years, first hospitalization for COVID-19, admitted between March 1 and May 2, 2020, at University of California, Los Angeles (UCLA) Medical Center, managed by an inpatient medicine service. MAIN MEASURES: Ferritin, C-reactive protein, lactate dehydrogenase, D-dimer, procalcitonin, white blood cell count, absolute lymphocyte count, temperature, and oxygen requirement were noted. KEY RESULTS: Of 99 patients, five required ED admission within 30 days, and another five required readmission. Fever within 24 h of discharge, oxygen requirement, and laboratory abnormalities were not associated with need for ED visit or readmission within 30 days of discharge after admission for COVID-19. CONCLUSION: Our data suggest that neither persistent fever, oxygen requirement, nor laboratory marker derangement was associated with need for acute care in the 30-day period after discharge for severe COVID-19. These findings suggest that physicians need not await the normalization of laboratory markers, resolution of fever, or discontinuation of oxygen prior to discharging a stable or improving patient with COVID-19.
Authors: Brandon Michael Henry; Maria Helena Santos de Oliveira; Stefanie Benoit; Mario Plebani; Giuseppe Lippi Journal: Clin Chem Lab Med Date: 2020-06-25 Impact factor: 3.694
Authors: Yan Deng; Wei Liu; Kui Liu; Yuan-Yuan Fang; Jin Shang; Ling Zhou; Ke Wang; Fan Leng; Shuang Wei; Lei Chen; Hui-Guo Liu Journal: Chin Med J (Engl) Date: 2020-06-05 Impact factor: 2.628
Authors: Cheng-Wei Huang; Joon S Park; Hubert Song; Vang Kou Khang; Albert S Yu; Huong Q Nguyen; Janet S Lee; Christopher C Subject; Ernest Shen Journal: J Gen Intern Med Date: 2022-09-14 Impact factor: 6.473